|
Name |
3-Methoxy-2-naphthol
|
| Molecular Formula | C11H10O2 | |
| IUPAC Name* |
3-methoxynaphthalen-2-ol
|
|
| SMILES |
COC1=CC2=CC=CC=C2C=C1O
|
|
| InChI |
InChI=1S/C11H10O2/c1-13-11-7-9-5-3-2-4-8(9)6-10(11)12/h2-7,12H,1H3
|
|
| InChIKey |
SJTNTIRIRIPZDV-UHFFFAOYSA-N
|
|
| Synonyms |
3-Methoxy-2-naphthol; 18515-11-2; 3-methoxynaphthalen-2-ol; 2-Naphthalenol, 3-methoxy-; 2-Hydroxy-3-methoxynaphthalene; 3-METHOXY-2-NAPHTHOL 97; 2-Naphthol, 3-methoxy-; 2-Methoxy-3-naphthol; 3-methoxy-2-naphthalenol; 3-Methoxy-2-naphthol #; 3-methoxy-naphthalen-2-ol; 3-Methoxy-2-naphthol, 97%; SCHEMBL6232041; BDBM36296; DTXSID40171723; ZINC402384; MFCD00029345; AKOS009143252; DB-128412; CS-0044849; D97763; J-011871
|
|
| CAS | 18515-11-2 | |
| PubChem CID | 599943 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 174.2 | ALogp: | 2.8 |
| HBD: | 1 | HBA: | 2 |
| Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 29.5 | Aromatic Rings: | 2 |
| Heavy Atoms: | 13 | QED Weighted: | 0.718 |
| Caco-2 Permeability: | -4.47 | MDCK Permeability: | 0.00002190 |
| Pgp-inhibitor: | 0.003 | Pgp-substrate: | 0.032 |
| Human Intestinal Absorption (HIA): | 0.005 | 20% Bioavailability (F20%): | 0.079 |
| 30% Bioavailability (F30%): | 0.394 |
| Blood-Brain-Barrier Penetration (BBB): | 0.374 | Plasma Protein Binding (PPB): | 95.62% |
| Volume Distribution (VD): | 0.886 | Fu: | 3.73% |
| CYP1A2-inhibitor: | 0.986 | CYP1A2-substrate: | 0.935 |
| CYP2C19-inhibitor: | 0.713 | CYP2C19-substrate: | 0.345 |
| CYP2C9-inhibitor: | 0.321 | CYP2C9-substrate: | 0.876 |
| CYP2D6-inhibitor: | 0.684 | CYP2D6-substrate: | 0.902 |
| CYP3A4-inhibitor: | 0.208 | CYP3A4-substrate: | 0.299 |
| Clearance (CL): | 13.238 | Half-life (T1/2): | 0.785 |
| hERG Blockers: | 0.052 | Human Hepatotoxicity (H-HT): | 0.095 |
| Drug-inuced Liver Injury (DILI): | 0.685 | AMES Toxicity: | 0.747 |
| Rat Oral Acute Toxicity: | 0.075 | Maximum Recommended Daily Dose: | 0.671 |
| Skin Sensitization: | 0.933 | Carcinogencity: | 0.784 |
| Eye Corrosion: | 0.654 | Eye Irritation: | 0.99 |
| Respiratory Toxicity: | 0.775 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC002077 | ![]() |
0.542 | D0E9CD | ![]() |
0.396 | ||
| ENC000033 | ![]() |
0.512 | D0DJ1B | ![]() |
0.377 | ||
| ENC001537 | ![]() |
0.490 | D05CKR | ![]() |
0.349 | ||
| ENC000169 | ![]() |
0.468 | D02NTO | ![]() |
0.333 | ||
| ENC000714 | ![]() |
0.440 | D0L5PO | ![]() |
0.328 | ||
| ENC001512 | ![]() |
0.426 | D04JEE | ![]() |
0.319 | ||
| ENC000172 | ![]() |
0.422 | D00CSQ | ![]() |
0.313 | ||
| ENC002427 | ![]() |
0.396 | D07MGA | ![]() |
0.307 | ||
| ENC000027 | ![]() |
0.396 | D09JUG | ![]() |
0.306 | ||
| ENC000068 | ![]() |
0.396 | D07HBX | ![]() |
0.306 | ||